Siemens Healthineers says it has completed a $1.1 billion buyout of Corindus Vascular Robotics and its robot-assisted device for coronary and peripheral vascular procedures. Siemens Healthineers believes the addition of its imaging and artificial intelligence tools to Corindus' robotics platform will help it garner a stronger foothold into the vascular robotics sector.
"The acquisition of Corindus, combined with Siemens' strong advanced therapies portfolio will help further advance the growth of vascular robotics," Michel Therin, president of advanced therapies at Siemens Healthineers, said in a statement.
